Thorikay M, Kramer S, Reynolds F H, Sorvillo J M, Doescher L, Wu T, Morris C A, Burtis W J, Insogna K L, Valenzuela D M
Oncogene Science, Inc., Manhasset, New York 11030.
Endocrinology. 1989 Jan;124(1):111-8. doi: 10.1210/endo-124-1-111.
PTH-like proteins (PTHLP), which are associated with humoral hypercalcemia of malignancy, have recently been purified. Isolation of their corresponding cDNAs has revealed that they are derived from a single gene. In this report a synthetic gene encoding PTHLP-(1-141), a 141-amino acid protein corresponding to the most abundant PTHLP cDNA detected in human tumors, was expressed in bacteria and purified to homogeneity. Recombinant (r) PTHLP-(1-141) migrates with an aberrantly high mol wt on sodium dodecyl sulfate-polyacrylamide gel electrophoresis, presumably as a result of its unusually basic pI. rPTHLP-(1-141), like PTH, induced hypercalcemia in rats, caused release of 45Ca from fetal rat bones, and stimulated the synthesis of cAMP by rat osteosarcoma cells and canine renal membrane preparations. A comparison of the abilities of rPTHLP-(1-141) and bovine PTH-(1-34) to stimulate cAMP synthesis indicated rPTHLP-(1-141) to be 5-fold more potent in the osteosarcoma assay, while nearly 30-fold less active in the renal membrane adenylate cyclase assay. Although 100-fold less potent than bovine PTH-(1-34) in promoting bone resorption, rPTHLP-(1-141) was a potent calcemic factor in vivo, inducing a rise in serum calcium from 10.4 to 14.5 mg/dl when infused into rats at 1.3 micrograms/h. These results support previous assumptions that PTHLP is the humoral factor responsible for humoral hypercalcemia of malignancy. In addition, they suggest substantial differences between PTHLP and PTH in the regulation of calcium homeostasis.
与恶性肿瘤体液性高钙血症相关的甲状旁腺激素样蛋白(PTHLP)最近已被纯化。其相应cDNA的分离表明它们源自单个基因。在本报告中,编码PTHLP-(1-141)的合成基因在细菌中表达并纯化至同质,PTHLP-(1-141)是一种141个氨基酸的蛋白质,对应于在人类肿瘤中检测到的最丰富的PTHLP cDNA。重组(r)PTHLP-(1-141)在十二烷基硫酸钠-聚丙烯酰胺凝胶电泳上以异常高的分子量迁移,推测是由于其异常碱性的pI。rPTHLP-(1-141)与甲状旁腺激素(PTH)一样,可诱导大鼠高钙血症,导致胎鼠骨骼释放45Ca,并刺激大鼠骨肉瘤细胞和犬肾膜制剂合成环磷酸腺苷(cAMP)。rPTHLP-(1-141)和牛PTH-(1-34)刺激cAMP合成能力的比较表明,rPTHLP-(1-141)在骨肉瘤试验中的效力高5倍,而在肾膜腺苷酸环化酶试验中的活性低近30倍。尽管rPTHLP-(1-141)在促进骨吸收方面的效力比牛PTH-(1-34)低100倍,但它在体内是一种有效的血钙因子,以1.3微克/小时的速度注入大鼠时,可使血清钙从10.4毫克/分升升至14.5毫克/分升。这些结果支持了先前的假设,即PTHLP是导致恶性肿瘤体液性高钙血症的体液因子。此外,它们表明PTHLP和PTH在钙稳态调节方面存在实质性差异。